Inhalation
Anesthesia Market Research Report: Information by Product (Sevoflurane,
Isoflurane, Desflurane), Application (Induction, Maintenance) and Region -
Global Forecast till 2025
Market Highlights
The Global Inhalation Anesthesia Market is expected to grow significantly over the
forecast period. It is anticipated that the market held a valuation of USD 1.12
billion in 2018 and is projected to register a CAGR of 3.8% over the forecast
period.
The increasing cases
of surgical procedures and the growing older population are the key factors
driving the inhalation anesthesia market. As per the report published by the
Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million
adults were dealing with at least one type of cardiovascular disease, which
eventually increases the cases of surgical procedures.
Various other factors
such as the advancements in inhalation
anesthesia, increasing geriatric population, untapped
emerging markets, rise in regulatory approvals, and increasing surgical
procedures are also expected to propel the growth of the market.
However, the
increasing concern about greenhouse gas emissions can hamper market growth over
the forecast period.
Segmentation
The global inhalation anesthesia
market is segmented based on product, application, and region.
The global market for inhalation
anesthesia, by product, is segmented into sevoflurane, isoflurane, and
desflurane.
Based on application, the market
is segmented into induction and maintenance.
Sevoflurane led the market in
2018 and is anticipated to grow at a lucrative rate over the forecast period.
The large share is due to its
wide usage in anesthesia induction owing to its therapeutic advantages and low
cost.
Browse Complete Report :https://www.marketresearchfuture.com/reports/inhalation-anesthesia-market-8059
Key Players
Some of the key players in the
global inhalation anesthesia market are Halocarbon Products Corporation,
Baxter, Hikima Pharmaceuticals plc., Lunan Pharmaceutical Group Co. Ltd,
Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd, Fresenius Kabi
AG, AbbVie Inc., and others.
Regional Analysis
In the current scope of the
study, the segments mentioned above are covered into the four global regions,
namely, the Americas, Europe, Asia-Pacific, and the Middle East and African
region.
The inhalation anesthesia market
in the Americas has further been segmented into North America and South
America, with the North American market divided into the US and Canada.
The European inhalation
anesthesia market has been segmented into Western Europe and Eastern Europe.
Western Europe has been classified as Germany, France, the UK, Italy, Spain,
and the rest of Western Europe. The inhalation anesthesia market in
Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. The inhalation anesthesia market in
the Middle East & Africa has been segmented into the Middle East and
Africa.
No comments:
Post a Comment